چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده | نفر چندم مقاله |
|---|---|
| سینا حسن نژاد | اول |
| آرش حاجی کمانج علیا | دوم |
| امین خامنه | سوم |
| لیلا واحدی | چهارم |
| عنوان | متن |
|---|---|
| خلاصه مقاله | Background: Following the COVID-19 pandemic, different drugs, including Hydroxychloroquine (HCQ) and chloroquine (CQ), have been used to treat this disease. Objective: The aim of study was to assess the efficacy of CQ & HCQ drugs in the treatment of patients infected with COVID-19. Methods: A search was performed in PubMed, Embase and Scopus databases on systematic review articles by the keywords “COVID-19” OR “SARS-CoV-2” AND “Hydroxychloroquine “or “Chloroquine” AND “Systematic Review” OR “Meta-analysis” Results: Out of 21 systematic review studies, 28.5% of studies have shown a positive effect for the use of HCQ and CQ and 28.5% of studies have suggested under certain conditions; however, 33.5% studies have recommended not using the drugs and 9.5% of studies did not suggest any use or non-use due to lack of sufficient evidence.Conclusion: Most of these studies, even studies that recommended the use of these two drugs, did not show a reduction in the risk of mortality in recipients of these two drugs. Summarizing the findings of these articles showed that although the need for an effective drug is essential in epidemic conditions. But the use of existing drugs without scientific support will not help to control pandemics. Even it may delay in finding the appropriate treatment. |
| کلمات کلیدی | COVID-19, Efficacy, Chloroquine, Hydroxychloroquine |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| Abstract 3.pdf | 1402/03/07 | 538456 | دانلود |
| Certifit Zahedan 3.pdf | 1402/03/07 | 1042162 | دانلود |
| Zahedan Ketab.pdf | 1402/03/16 | 2902571 | دانلود |
| 22.png | 1402/04/03 | 114886 | دانلود |
